Senegal Becomes the First Gavi-supported Country in West Africa to Introduce HPV Vaccine into its Routine Immunization Program

The human papillomavirus (HPV) vaccine, which protects against cervical cancer, was introduced into Senegal’s national routine immunization program at the end of October by Senegal President, Macky Sall. The first vaccine was delivered during a high level event attended by the First Lady of Senegal and 14 other First Ladies from the African continent.

The vaccines, funded by Gavi, the Vaccine Alliance and the Government of Senegal, will reach close to 200,000 nine-year-old girls across the country this year and a further 900,000 girls aged 11-14 years next year. UNICEF, WHO and partners will work on implementation alongside the Senegal Ministry of Health and Social Welfare and the Ministry of National Education.

Leave a Reply

Your email address will not be published.

You May Also Like

Applications Open for New Fellowship on COVID-19 Recovery for Routine Immunization Programs

What: WHO, in partnership with Sabin’s Boost Community, is offering a fellowship program for national and sub-national immunisation staff to support them as they plan and implement activities for the recovery and strengthening of their countries’ immunisation programmes. When: Starting Wednesday, May 11, 2022, this cohort will participate in a comprehensive program over the course … Continued

Using Digital Technology to Reach More Children with Immunizations

This article originally appeared on Johns Hopkins Center for Communication Programs. Below is an excerpt. Using real-time monitoring of childhood immunization campaigns can enable real-time decision-making and ensure that children in hard-to-reach areas can be located and vaccinated in a timely manner, according to research from the Johns Hopkins Center for Communication Programs. The report, supported by … Continued

Vaccine transportation – A challenging journey (Vietnam News)

For medical staff working in remote and rural areas, vaccine transportation is a long and tough journey due to harsh natural and geographical conditions. For a product that is required to be continuously stored at temperatures between 2-8 degrees Celsius, vaccine storage during transportation in these areas encounters various difficulties. To learn more about how  … Continued